172 related articles for article (PubMed ID: 38280659)
21. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder.
Stefani A; Iranzo A; Holzknecht E; Perra D; Bongianni M; Gaig C; Heim B; Serradell M; Sacchetto L; Garrido A; Capaldi S; Sánchez-Gómez A; Cecchini MP; Mariotto S; Ferrari S; Fiorini M; Schmutzhard J; Cocchiara P; Vilaseca I; Brozzetti L; Monaco S; Jose Marti M; Seppi K; Tolosa E; Santamaria J; Högl B; Poewe W; Zanusso G;
Brain; 2021 May; 144(4):1118-1126. PubMed ID: 33855335
[TBL] [Abstract][Full Text] [Related]
22. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
Okuzumi A; Hatano T; Matsumoto G; Nojiri S; Ueno SI; Imamichi-Tatano Y; Kimura H; Kakuta S; Kondo A; Fukuhara T; Li Y; Funayama M; Saiki S; Taniguchi D; Tsunemi T; McIntyre D; Gérardy JJ; Mittelbronn M; Kruger R; Uchiyama Y; Nukina N; Hattori N
Nat Med; 2023 Jun; 29(6):1448-1455. PubMed ID: 37248302
[TBL] [Abstract][Full Text] [Related]
23. Are We Ready for Detecting α-Synuclein Prone to Aggregation in Patients? The Case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as Diagnostic Tools.
Paciotti S; Bellomo G; Gatticchi L; Parnetti L
Front Neurol; 2018; 9():415. PubMed ID: 29928254
[TBL] [Abstract][Full Text] [Related]
24. Development of α-Synuclein Real-Time Quaking-Induced Conversion as a Diagnostic Method for α-Synucleinopathies.
Nakagaki T; Nishida N; Satoh K
Front Aging Neurosci; 2021; 13():703984. PubMed ID: 34650422
[TBL] [Abstract][Full Text] [Related]
25. Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.
Brockmann K; Quadalti C; Lerche S; Rossi M; Wurster I; Baiardi S; Roeben B; Mammana A; Zimmermann M; Hauser AK; Deuschle C; Schulte C; Waniek K; Lachmann I; Sjödin S; Brinkmalm A; Blennow K; Zetterberg H; Gasser T; Parchi P
Acta Neuropathol Commun; 2021 Oct; 9(1):175. PubMed ID: 34717775
[TBL] [Abstract][Full Text] [Related]
26. Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC.
Groveman BR; Orrù CD; Hughson AG; Raymond LD; Zanusso G; Ghetti B; Campbell KJ; Safar J; Galasko D; Caughey B
Acta Neuropathol Commun; 2018 Feb; 6(1):7. PubMed ID: 29422107
[TBL] [Abstract][Full Text] [Related]
27. Detection of α-synuclein in CSF by RT-QuIC in patients with isolated rapid-eye-movement sleep behaviour disorder: a longitudinal observational study.
Iranzo A; Fairfoul G; Ayudhaya ACN; Serradell M; Gelpi E; Vilaseca I; Sanchez-Valle R; Gaig C; Santamaria J; Tolosa E; Riha RL; Green AJE
Lancet Neurol; 2021 Mar; 20(3):203-212. PubMed ID: 33609478
[TBL] [Abstract][Full Text] [Related]
28. In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
Donadio V; Wang Z; Incensi A; Rizzo G; Fileccia E; Vacchiano V; Capellari S; Magnani M; Scaglione C; Stanzani Maserati M; Avoni P; Liguori R; Zou W
Neurology; 2021 May; 96(20):e2513-e2524. PubMed ID: 33837116
[TBL] [Abstract][Full Text] [Related]
29. Preclinical Detection of Alpha-Synuclein Seeding Activity in the Colon of a Transgenic Mouse Model of Synucleinopathy by RT-QuIC.
Han JY; Shin C; Choi YP
Viruses; 2021 Apr; 13(5):. PubMed ID: 33926043
[TBL] [Abstract][Full Text] [Related]
30. α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
Schmitz M; Candelise N; Canaslan S; Altmeppen HC; Matschke J; Glatzel M; Younas N; Zafar S; Hermann P; Zerr I
Transl Neurodegener; 2023 Mar; 12(1):12. PubMed ID: 36915212
[TBL] [Abstract][Full Text] [Related]
31. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories.
Bargar C; De Luca CMG; Devigili G; Elia AE; Cilia R; Portaleone SM; Wang W; Tramacere I; Bistaffa E; Cazzaniga FA; Felisati G; Legname G; Di Fonzo A; Xu R; Gunzler SA; Giaccone G; Eleopra R; Chen SG; Moda F
Mol Neurodegener; 2021 Dec; 16(1):82. PubMed ID: 34895275
[TBL] [Abstract][Full Text] [Related]
32. Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays.
Candelise N; Schmitz M; Thüne K; Cramm M; Rabano A; Zafar S; Stoops E; Vanderstichele H; Villar-Pique A; Llorens F; Zerr I
Transl Neurodegener; 2020; 9():5. PubMed ID: 31988747
[TBL] [Abstract][Full Text] [Related]
33. Detection of skin α-synuclein using RT-QuIC as a diagnostic biomarker for Parkinson's disease in the Chinese population.
Li J; Duan S; Yang J; Zheng H; Yuan Y; Tang M; Wang Y; Liu Y; Xia Z; Luo H; Xu Y
Eur J Med Res; 2024 Feb; 29(1):114. PubMed ID: 38336827
[TBL] [Abstract][Full Text] [Related]
34. Performance of αSynuclein RT-QuIC in relation to neuropathological staging of Lewy body disease.
Hall S; Orrù CD; Serrano GE; Galasko D; Hughson AG; Groveman BR; Adler CH; Beach TG; Caughey B; Hansson O
Acta Neuropathol Commun; 2022 Jun; 10(1):90. PubMed ID: 35733234
[TBL] [Abstract][Full Text] [Related]
35. Misfolded alpha-synuclein detection by RT-QuIC in dementia with lewy bodies: a systematic review and meta-analysis.
Peña-Bautista C; Kumar R; Baquero M; Johansson J; Cháfer-Pericás C; Abelein A; Ferreira D
Front Mol Biosci; 2023; 10():1193458. PubMed ID: 37266333
[No Abstract] [Full Text] [Related]
36. Seeding variability of different alpha synuclein strains in synucleinopathies.
Candelise N; Schmitz M; Llorens F; Villar-Piqué A; Cramm M; Thom T; da Silva Correia SM; da Cunha JEG; Möbius W; Outeiro TF; Álvarez VG; Banchelli M; D'Andrea C; de Angelis M; Zafar S; Rabano A; Matteini P; Zerr I
Ann Neurol; 2019 May; 85(5):691-703. PubMed ID: 30805957
[TBL] [Abstract][Full Text] [Related]
37. Detecting Alpha Synuclein Seeding Activity in Formaldehyde-Fixed MSA Patient Tissue by PMCA.
Becker K; Wang X; Vander Stel K; Chu Y; Kordower J; Ma J
Mol Neurobiol; 2018 Nov; 55(11):8728-8737. PubMed ID: 29589283
[TBL] [Abstract][Full Text] [Related]
38. Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden.
Bentivenga GM; Mammana A; Baiardi S; Rossi M; Ticca A; Magliocchetti F; Mastrangelo A; Poleggi A; Ladogana A; Capellari S; Parchi P
Acta Neuropathol; 2024 Jan; 147(1):18. PubMed ID: 38240849
[TBL] [Abstract][Full Text] [Related]
39. Ultrasensitive RT-QuIC Seed Amplification Assays for Disease-Associated Tau, α-Synuclein, and Prion Aggregates.
Saijo E; Groveman BR; Kraus A; Metrick M; Orrù CD; Hughson AG; Caughey B
Methods Mol Biol; 2019; 1873():19-37. PubMed ID: 30341601
[TBL] [Abstract][Full Text] [Related]
40. Application of α-Syn Real-Time Quaking-Induced Conversion for Brain and Skin Specimens of the Chinese Patients With Parkinson's Disease.
Chen DD; Jiao L; Huang Y; Xiao K; Gao LP; Chen C; Shi Q; Dong XP
Front Aging Neurosci; 2022; 14():898516. PubMed ID: 35847665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
